Ignite Creation Date:
2025-12-26 @ 11:12 PM
Ignite Modification Date:
2025-12-26 @ 11:12 PM
Study NCT ID:
NCT04905212
Status:
TERMINATED
Last Update Posted:
2023-12-06
First Post:
2021-05-21
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Telitacicept for Injection (RC18) in Subjects With IgA Nephropathy
Sponsor:
RemeGen Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-04
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2021-05-21
First Submit QC Date:
None
Study First Post Date:
2021-05-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-29
Last Update Post Date:
2023-12-06
Last Update Post Date Type:
ACTUAL